Abstract
We herein report the ammonium salt‐catalyzed synthesis of chiral 3,3‐disubstituted isoindolinones bearing a heteroatom functionality in the 3‐position. A broad variety of differently substituted CF3S‐ and RS‐derivatives were obtained with often high enantioselectivities when using Maruoka's bifunctional chiral ammonium salt catalyst. In addition, a first proof‐of‐concept for the racemic synthesis of the analogous F‐containing products was obtained as well, giving access to one of the rare examples of a fairly stable α‐F‐α‐amino acid derivative.

Keywords: Organocatalysis, Asymmetric phase-transfer catalysis, Bifunctional catalysis, Heterofunctionalization, Organofluorine chemistry

Introduction
Isoindolinones have emerged as a promising class of chiral small molecule heterocycles with interesting biological properties over the course of the last years.[ 1 , 2 ] A variety of different strategies to access these versatile targets in an enantioselective manner have been introduced [2] and especially the asymmetric synthesis of 3,3‐disubstituted derivatives (Scheme 1A) became a contemporary field of interest.[ 3 , 4 , 5 , 6 , 7 , 8 , 9 ] Noteworthy, whereas several conceptually complementary methods to access enantioenriched 3,3‐disubstituted isoindolinones bearing an all‐carbon stereogenic center have been reported,[ 3 , 4 ] the enantioselective (catalytic) synthesis of 3,3‐disubstituted isoindolinones with a heteroatom‐functionality in the 3‐position has so far received less attention.[ 5 , 6 , 7 ]
Scheme 1.

Targeted asymmetric synthesis of 3‐heterofunctionalized 3,3‐disubstituted isoindolinones.
One recently introduced strategy for the synthesis of 3,3‐disubstituted isoindolinones relies on the asymmetric α‐functionalization of EWG‐containing isoindolinones 1.[ 8 , 9 ] Until now, this has mainly been used for asymmetric C−C‐bond forming reactions, [8] whereas, to the best of our knowledge, so far no enantioselective α‐heterofunctionalizations of compounds 1 with electrophilic heteroatom‐transfer reagents have been reported. We have a strong research interest in asymmetric ammonium salt ion pairing catalysis,[ 10 , 11 ] with a special focus on asymmetric α‐heterofunctionalizations of different (pro)‐nucleophiles. [12] Considering the general potential of chiral ammonium salt catalysis for stereoselective α‐heterofunctionalization reactions, [13] as well as for the asymmetric control of pronucleophiles 1, [8b] we now became interested in the development of new strategies for the synthesis of 3‐heterofunctionalized isoindolinones 2 (i. e. CF3S‐, RS‐, F‐substituted ones, Scheme 1B).[ 14 , 15 , 16 , 17 , 18 ]
Results and Discussion
Based on the widespread interest in asymmetric trifluoromethylthiolation reactions[ 14 , 15 ] and our own recent experience in this field, [12a] we first focused on the asymmetric α‐trifluoromethylthiolation of 3‐cyano p‐methoxybenzyl‐(PMB)‐protected isoindolinone 1 a (Table 1) using different established, as well as newly designed, chiral ammonium salt catalysts A–D (Figure 1).
Table 1.
Identification of the best‐suited catalyst and conditions for the synthesis of compounds 2 a.[a]
|
| |||||
|---|---|---|---|---|---|
|
Entry |
Cat. |
Base (equiv.) |
Solv. |
Yield[b] [%] |
e.r.[c] |
|
1 |
A1 |
K2CO3 (1) |
MTBE |
70 |
50:50 |
|
2 |
A2 |
K2CO3 (1) |
MTBE |
74 |
50:50 |
|
3 |
D1 |
K2CO3 (1) |
MTBE |
82 |
52:48 |
|
4 |
B1 |
K2CO3 (1) |
MTBE |
26 |
39:61 |
|
5 |
B2 |
K2CO3 (1) |
MTBE |
25 |
43:57 |
|
6 |
C1 |
K2CO3 (1) |
MTBE |
86 |
40:60 |
|
7 |
B3 |
K2CO3 (1) |
MTBE |
80 |
30:70 |
|
8 |
D2 |
K2CO3 (1) |
MTBE |
90 |
97:3 (86:14)[d] |
|
9 |
D2 |
K2CO3 (1) |
toluene |
50[e] |
76:24 |
|
10 |
D2 |
K2CO3 (1) |
CH2Cl2 |
44[e] |
72:28 |
|
11 |
D2 |
K2CO3 (1) |
Et2O |
82 |
95:5 |
|
12 |
D2 |
K2CO3 (1) |
THF |
75 |
84:16 |
|
13 |
D2 |
K2CO3 (10% aq.) (1) |
MTBE |
77 |
81:19 |
|
14 |
D2 |
K2CO3 (0.2) |
MTBE |
95 |
97:3 |
|
15 |
D2 |
Cs2CO3 (0.2) |
MTBE |
92 |
96:4 |
|
16 |
D2 |
K2HPO4 (0.2) |
MTBE |
95 |
97:3 |
|
17[f] |
D2 |
K2CO3 (0.2) |
MTBE |
95 |
98:2 |
[a] Unless otherwise stated all reactions were carried out using 0.1 mmol 1 a, 0.12 mmol 5 (1.2 equiv.) and 5 mol% of the catalyst with the indicated base and solvent at room temperature (20 h reaction time, 0.05 M with respect to 1 a); PMB=p‐methoxy‐benzyl.
[b] Isolated yields.
[c] Determined by HPLC using a chiral stationary phase. The absolute configuration of the major enantiomer was assigned in analogy to derivative 2 e [26] which was analyzed by single crystal X‐ray diffraction.
[d] Using 1 mol% catalyst.
[e] Incomplete conversion.
[f] Reaction carried out at −20 °C.
Figure 1.

Asymmetric ammonium salt catalysts used herein.
Table 1 gives an illustrative overview about the most significant results obtained in a broad screening of different catalysts and conditions for the enantioselective synthesis of the CF3S‐containing isoindolinone 2 a. As CF3S‐transfer agent we used the well‐documented succinimide‐based reagent 5 [14] but we also tested the analogous phthalimide‐based derivative which performed literally identical herein. First experiments with the classical well‐established Cinchona alkaloid‐based catalysts A1 and A2 [10] and with the commercially available Maruoka salt D1 [19] were rather disappointing, providing 2 a in a racemic manner only (entries 1–3). First measurable levels of enantioselectivities (e.r.∼60:40) could be obtained by using our bifunctional urea‐ and thiourea‐containing ammonium salts B1 and B2, [20] albeit with low yields only and accompanied by the formation of significant amounts of uncharacterized side‐products (entries 4 and 5).
Based on these results, that indicated the potential of bifunctional ammonium salt catalysts for this application, we next wanted to use the synthesis of 2 a as a test reaction for the development of novel alternative bifunctional ammonium salts. Here we followed two different strategies. First, we wanted to test an alternative chiral diamine backbone with a different linker length between the two functional groups. One easily accessible chiral diamine that has so far not been explored for asymmetric ammonium salt catalysis is isophorone diamine. [21] The synthesis of the corresponding chiral ammonium salt C1 was possible in an analogous manner as reported previously for compounds B.[ 20 , 22 ] In contrast to catalysts B1 and B2 the new derivative C1 gave product 2 a in a good isolated yield of 86%, but unfortunately the enantioselectivity could not be improved (entry 6) and no further optimization was possible.
Alternatively, we wanted to expand the diversity and applicability of our cyclohexanediamine‐system B by introducing guanidines as potential H‐bonding motives. Surprisingly, despite of all the value of chiral guanidines for asymmetric catalysis,[ 23 , 24 ] such a chiral ammonium salt‐guanidine hybrid system has, to the best of our knowledge, so far not been reported. We found that the synthesis of the unprecedented bifunctional ammonium salt B3 was indeed possible [22] and that this catalyst also allowed for a better catalytic performance than B1 and B2 (entry 7). Unfortunately, we were not able to improve this result further and other ammonium salt‐guanidine derivatives could so far not be accessed. Thus, despite this interesting proof‐of‐concept for this novel class of catalysts, we stopped testing our own hybrid systems and finally tested Maruoka's bifunctional ammonium salt D2 [25] as well. Literally the first experiment with 5 mol% of this nowadays commercially available catalyst gave product 2 a in 90% isolated yield with an excellent enantiomeric ratio of 97:3 (unfortunately the e.r. dropped to 86:14 when using 1 mol% D2; entry 8).
Based on these promising initial results, we screened a variety of different bases and temperatures (entries 8–16) and realized that actually our initial conditions using solid K2CO3 in MTBE were almost the best. The only minor improvement that could be achieved in this optimization was to carry out the reaction with catalytic amounts of external base only (see entries 14–16), which can be explained by the fact that the in situ formed succinimide acts as a base itself (which is in analogy to our previous observations in the trifluoromethylthiolation of masked β‐amino acids [12a] ). In addition, a further slight increase in enantioselectivity was observed when carrying out the reaction at −20 °C, thus allowing for the asymmetric synthesis of 2 a in high yields and with excellent enantioselectivities under biphasic conditions (entry 17).
With these optimized conditions at hand, we next investigated the generality of this reaction (Scheme 2).
Scheme 2.

Application scope of the asymmetric α‐trifluoromethylthiolation of various isoindolinones 1 (the (+)‐enantiomers of products 2 were favored in all cases); α‐Np=1‐naphthyl.
First, we carried out a systematic variation of the N‐protecting group by introducing different benzylic groups (giving products 2 a–2 h), several aryl substituents (products 2 i–2 k) and various alkyl groups (products 2 l–2 o). Surprisingly, the obtained enantioselectivities varied significantly. For example, the presence of a simple N‐benzyl‐group (product 2 b) led to clearly inferior results (e.r.=80:20) compared to the other N‐benzyl derivatives 2 a, 2 c–2 h (which varied between e.r.=90:10–98:2). X‐ray diffraction analysis of single crystals of target 2 e allowed us to assign the (S)‐configuration for this product [26] and the other derivatives were then assigned in analogy. When testing different N‐aryl‐substituents (products 2 i–2 k) the outcome was also very much dependent on the nature of this group, which was especially pronounced when comparing the results obtained for the N‐PMP‐containing 2 i (e.r.=96:4) and the N‐phenyl‐substituted 2 j (e.r.=61:39). On the other hand, several N‐alkyl groups were well‐tolerated (2 l–2 n; e.r.>95:5) and only the trifluoroethyl‐substituted 2 o was obtained with a significantly reduced selectivity (e.r.=70:30). It has to be pointed out that this strong difference in performance really came as a surprise, illustrating that the N‐substituent has a pronounced (steric and/or electronic) impact on the catalyst‐substrate interaction in this reaction.
Interestingly, substitutions at the isoindolinone‐backbone also strongly influenced the outcome (2 p–2 s). While the presence of fluorine in the 5‐position was well‐tolerated (2 q; e.r.=96:4), substituents in the 6‐position led to significantly lower enantioselectivities (2 p, 2 r, 2 s; e.r.<76:24). Even more striking, a substituent in the 4‐position (2 v) not only decreased the enantioselectivity, but also resulted in a significantly lower conversion and yield. Finally, we also tested analogous ester derivatives but as can be seen for products 2 t and 2 u, the ester group led to lower selectivities (e.r.<80:20) compared to the initially used nitrile group.
Overall, these investigations revealed a rather strong and somewhat unexpected influence of the nature of the substrates on the enantioselectivities of these α‐trifluoromethylthiolation reactions. The exact reasons for these remarkable selectivity dependencies on seemingly subtle variations in the starting materials are not yet clearly understood. However, these results demonstrate that the stereo‐defining non‐covalent catalyst‐substrate interactions are supposed to be rather sensitive to disturbance by steric and/or electronic alterations in the starting materials. Nevertheless, despite the somewhat lower generality of this asymmetric α‐trifluoromethylthiolation protocol, this methodology still gives access to a broad variety of differently substituted novel 3‐SCF3‐containing 3,3‐disubstituted isoindolinones 2 in high yields with moderate to excellent enantioselectivities.
Building on the knowledge gathered hereby, we also tested analogous α‐sulfanylation reactions[ 16 , 17 ] to access products 3 (Scheme 3). Literally the first experiment using the conditions developed for the trifluoromethylthiolation (Scheme 2) gave product 3 a with almost perfect enantioselectivity (e.r.=99:1). Based on this very encouraging initial result, which makes further optimization more or less unnecessary, we immediately used these conditions for a variety of different combinations of isoindolinones 1 and electrophiles 6 or 7 (it should be noted that we carried out a few experiments with different conditions, but as expected, no further improvement was possible).
Scheme 3.

Application scope for the asymmetric α‐sulfanylation of isoindolinones 1 (the (+)‐enantiomers of products 3 were favored in all cases).
As outlined in Scheme 3, a variety of different nucleophile/electrophile combinations were well tolerated. Most targets 3 were obtained in satisfying yields with good to excellent enantioselectivities (up to e.r.=99.5:0.5) and overall this reaction was found to be more generally applicable compared to the synthesis of the SCF3‐products 2. More specifically, also ester‐containing products 3 d and 3 e were accessed with reasonable selectivities, although again the nature of the N‐protecting group turned out to have a significant effect. In addition, a broad variety of different S‐transfer agents were well tolerated (compare products 3 f–3 n) and only the ArS‐containing targets 3 j and 3 k were obtained with slightly reduced selectivities. Synthesis of the thiophosphate 3 o was in principle possible as well, but unfortunately in this case only racemic product could be obtained. Also, in sharp contrast to the synthesis of products 2, ring substitutions were much better tolerated herein (products 3 p–3 s), underscoring the broad applicability of this α‐sulfanylation reaction.
Next, we also investigated the (asymmetric) electrophilic α‐fluorination of isoindolinones 1 (Scheme 4). [27] Hereby, our initial focus was on the feasibility of this transformation and the stability of the α‐fluorinated products 4 in general. Our concerns related to the stability of compounds 4 are based on the fact that these compounds contain the fragile N−C−F motive. This structural element is well‐known to rapidly eliminate fluoride, which is one of the main reasons why α‐F‐α‐amino acid derivatives are very rare and sensitive motives.[ 28 , 29 , 30 ] However, given the fact that the presence of an electron‐withdrawing N‐substituent is supposed to increase the stability of the α‐F‐α‐amino acid motive[ 29 , 30 ] we tested the α‐fluorination of nucleophilic isoindolinones 1.
Scheme 4.

Proof‐of‐concept for the α‐fluorination of isoindolinones 1.
Indeed, it was possible to carry out the racemic fluorination of the nitrile‐based 1 a with NFSI (8) in the presence of benzyltriethylammonium chloride (TEBAC) as an achiral ammonium salt phase‐transfer catalyst (Scheme 4). Noteworthy, product 4 a turned out to be sufficiently stable to be fully characterized by means of NMR, HRMS and even single crystal X‐ray analysis. [26] However, it was also found that this compound decomposes in the presence of solvents, acids and bases. When testing the α‐fluorination of differently substituted starting materials 1 the outcome was unfortunately less encouraging. For example, the corresponding N‐PMB‐containing starting material 1 a only gave traces of the corresponding α‐fluorinated product (accompanied with significant amounts of decomposition products). Analogous ester‐based substrates were tested either and although product 4 b could be obtained in reasonable yield, it was found to be relatively unstable as well and other ester derivatives turned out to be capricious too (mainly formation of decomposition products again, indicating that α‐fluorination proceeds but that the products 4 are not stable).
Nevertheless, based on the proof‐of‐concept for the racemic formation of 4 a and 4 b we also tested the asymmetric variant for the synthesis of 4 a. Maruoka's bifunctional catalyst D2 allowed for reasonable conversion (65% isolated yield), while our bifunctional systems B did not lead to any product formation. Noteworthy, we observed almost quantitative decomposition when subjecting 4 a to HPLC analysis and we thus measured the e.r. by using Kim's chiral Al‐based NMR shift reagent, [31] which was recently found to be a powerful tool to determine the e.r. of chiral fluorinated targets. [32] Unfortunately however, we only observed very low levels of asymmetric induction (e.r.=55:45) [22] and therefore, considering the pronounced lability of these compounds as well, did not investigate the asymmetric synthesis of compounds 4 further.
Finally, we wanted to demonstrate the suitability of products 2 and 3 for further transformations. As outlined in Scheme 5, standard functional group manipulations like nitrile hydrolysis (giving products 9 a and 9 b without any loss of enantiomeric composition when carried out on enantioenriched starting material 2 q), N‐Boc‐deprotection (product 11) and ester hydrolysis (product 12) were carried out straightforwardly. In addition, product 3 c could undergo an intramolecular Houben‐Hoesch reaction to access the tetracyclic product 10 directly (with almost complete preservation of its enantioenrichment). It should be emphasized that no further optimizations to improve the isolated yields were undertaken and that these reactions mainly serve as a proof‐of‐concept to illustrate the versatility of these compounds.
Scheme 5.

Further transformations of products 2 and 3.
Conclusion
We succeeded in developing efficient protocols to access a broad variety of differently substituted 3‐CF3S‐ and 3‐RS‐containing 3,3‐disubstituted isoindolinones 2 and 3 by means of asymmetric ammonium salt‐catalyzed electrophilic α‐heterofunctionalizations of the nucleophilic isoindolinones 1. Key to success was the use of bifunctional chiral ammonium salt catalysts, i. e. Maruoka's free OH‐containing binaphthyl‐based salt D2. In addition, we also carried out the racemic α‐fluorination of starting materials 1 to access the compounds 4. These products contain the labile α‐F‐α‐amino acid motive but, depending on conditions and substitution pattern, we were able to isolate and characterize these sensitive compounds.
Experimental Section[22]
General Procedure for the Asymmetric Syntheses of Products 2 and 3
Isoindolinone 1 (0.10 mmol), catalyst D2 (0.005 mmol) and K2CO3 (0.02 mmol) were dissolved in MTBE (2 mL) at −20 °C and stirred for 15 min. Reagent 5, 6 or 7 (0.105 mmol) was added at once and the suspension was stirred at −20 °C. After 20 h, the reaction mixture was diluted with Et2O (5 mL) and filtered through a pad of Na2SO4 (washed with Et2O). The solvent was evaporated and the crude product was purified by column chromatography (silica gel, heptanes/EtOAc) to give pure enantioenriched isoindolinones 2 and 3. All the analytical details for the new compounds can be found in the online supporting information.
Representative Analytic Details for Products 2 a and 3 a
2 a: Prepared following the general procedure and obtained as a colorless powder (35.9 mg, 0.095 mmol, 95%, e.r.=98:2, m.p.=98–100 °C). Rf (heptanes/EtOAc=2/1)=0.50. [α]D 22 (c=0.80, CHCl3)=+25.1°. 1H NMR (300 MHz, δ, CDCl3, 298 K): 7.94 (d, J=7.4 Hz, 1H), 7.83 (d, J=7.6 Hz, 1H), 7.75 (td, J=7.6, 7.5, 1.3 Hz, 1H), 7.66 (td, J=7.4, 7.4, 1.2 Hz, 1H), 7.41 (d, J=8.6 Hz, 2H), 6.88 (d, J=8.7 Hz, 2H), 5.26 (d, J=15.3 Hz, 1H), 4.57 (d, J=15.3 Hz, 1H), 3.78 (s, 3H).13C NMR (75 MHz, δ, CDCl3, 298 K): 166.0, 159.9, 139.8, 133.9, 131.8, 130.6, 129.5, 127.5 (q, CF3, J CF=311.9 Hz), 126.7, 124.8, 124.0, 123.9, 114.2, 112.1, 65.5, 65.4, 65.4, 65.4, 55.3, 43.9. 19F NMR (471 MHz, δ, CDCl3, 298 K): −37.3 (s, 3F). HRMS (ESI): calcd m/z for C18H13F3N2O2S: 379.0723 [M+H]+; found: 379.0722. HPLC (Chiralpak AD‐H, eluent: hexane:i‐PrOH=10:1, 0.5 mL/min, 10 °C) retention times: tminor=20.6 min, tmajor=18.9 min).
3 a: Prepared according to the general procedure and obtained as a colorless oil (35.2 mg, 0.088 mmol, 88%, e.r.=99:1). Rf (heptanes/EtOAc=2/1)=0.45. [α]D 22 (c=1.00, CHCl3)=+31.5°; 1H NMR (300 MHz, δ, CDCl3, 298 K): 7.97–7.84 (m, 1H), 7.76–7.57 (m, 3H), 7.51–7.43 (m, 2H), 7.34–7.29 (m, 1H), 7.18–7.16 (m, 2H), 6.90–6.84 (m, 2H), 6.84–6.76 (m, 2H), 4.80 (d, J=15.1 Hz, 1H), 4.69 (d, J=15.1 Hz, 1H), 3.79 (s, 3H), 3.07 (d, J=12.4 Hz, 1H), 3.00 (d, J=12.3 Hz, 1H). 13C NMR (75 MHz, δ, CDCl3, 298 K): 166.7, 159.6, 141.0, 134.3, 133.8, 131.1, 130.8, 130.4, 129.0, 128.7, 128.0, 127.8, 124.3, 123.6, 114.2, 114.1, 65.2, 55.4, 43.8, 34.0. HRMS (ESI): calcd m/z for C24H21N2O2S: 401.1318 [M+H]+; found: 401.1325. HPLC (YMC CHIRAL ART Amylose‐SA, eluent: hexane:i‐PrOH=100:1, 0.5 mL/min, 10 °C) retention times: tminor=50.3 min, tmajor=42.6 min.
Racemic Synthesis of 4 a
Isoindolinone 1 a (0.1 mmol), NFSI 8 (0.2 mmol), TEBAC (0.01 mmol) and Cs2CO3 (0.2 mmol) were mixed together in MTBE (2 mL) and stirred at room temperature overnight. After completion of the reaction (as indicated by TLC), the suspension was diluted with Et2O (5 mL) and filtered through a pad of celite (washed with Et2O). The solvent was evaporated and the crude mixture was purified by column chromatography (silica gel, heptanes/EtOAc) to give product 4 a as light‐yellow solid (23.1 mg, 0.078 mmol, 78%). Rf (heptanes/EtOAc=2/1)=0.50. m.p.=143–145 °C. 1H NMR (700 MHz, δ, CDCl3, 298 K): 7.96 (d, J=7.5 Hz, 1H), 7.85 (d, J=7.6 Hz, 1H), 7.80 (t, J=7.5, 7.5 Hz, 1H), 7.75 (t, J=7.5, 7.5 Hz, 1H), 7.42 (d, J=9.0 Hz, 2H), 7.04 (d, J=8.9 Hz, 2H), 3.86 (s, 3H). 13C NMR (176 MHz, δ, CDCl3, 298 K): 165.9, 165.9, 160.3, 137.8, 137.6, 134.5, 134.4, 133.0, 133.0, 129.6, 129.1, 125.4, 125.0, 123.6, 115.2, 113.2, 112.9, 95.0, 93.8, 55.6. 19F NMR (282 MHz, δ, CDCl3, 298 K): −105.0. HRMS (ESI): calcd m/z for C17H13FN2O2: 297.1034 [M+H]+; found: 297.1040.
Supporting information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
Acknowledgements
This work was generously supported by the Austrian Science Funds (FWF): Projects No. P30237 and No. P31784. The used NMR spectrometers were acquired in collaboration with the University of South Bohemia (CZ) with financial support from the European Union through the EFRE INTERREG IV ETC‐AT‐CZ program (project M00146, “RERI‐uasb”). We are grateful to Thomas Bögl (JKU Linz) for support with HRMS analysis. J.O. wishes to thank Radka Opatrilova (MUNI Brno) for her kind support of the sabbatical leave.
A. Eitzinger, J. Otevrel, V. Haider, A. Macchia, A. Massa, K. Faust, B. Spingler, A. Berkessel, M. Waser, Adv. Synth. Catal. 2021, 363, 1955.
References
- 1. Speck K., Magauer T., Beilstein J. Org. Chem. 2013, 9, 2048–2078. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.
- 2a. Di Mola A., Palombi L., Massa A. in Targets in Heterocyclic Systems: Chemistry and Properties; Vol. 18 (Ed.: Attanasi O. A.), Società Chimica Italiana, Rome, Italy, 2014; pp. 113–140; [Google Scholar]
- 2b. Gao W., Chen M., Ding Q., Peng Y., Chem. Asian J. 2019, 14, 1306–1322. [DOI] [PubMed] [Google Scholar]
- 3.For selected impressive examples for the catalytic asymmetric generation of 3,3-disubstituted isoindolinones with an all-carbon stereogenic center:
- 3a. Yu X., Wang Y., Wu G., Song H., Zhou Z., Tang C., Eur. J. Org. Chem. 2011, 3060–3066; [Google Scholar]
- 3b. Yang G., Shen C., Zhang W., Angew. Chem. Int. Ed. 2012, 51, 9141–9145; [DOI] [PubMed] [Google Scholar]
- 3c. Nishimura T., Noishiki A., Ebe Y., Hayashi T., Angew. Chem. Int. Ed. 2013, 52, 1777–1780; [DOI] [PubMed] [Google Scholar]
- 3d. Ye B., Cramer N., Angew. Chem. Int. Ed. 2014, 53, 7896–7899; [DOI] [PubMed] [Google Scholar]
- 3e. Li T., Zhou C., Yan X., Wang J., Angew. Chem. Int. Ed. 2018, 57, 4048–4052; [DOI] [PubMed] [Google Scholar]
- 3f. Unhale R. A., Sadhu M. M., Ray S. K., Biswas R. G., Singh V. K., Chem. Commun. 2018, 54, 3516–3519; [DOI] [PubMed] [Google Scholar]
- 3g. Feng F.-F., Li J.-S., Li S., Ma J.-A., Adv. Synth. Catal. 2019, 361, 4222–4226; [Google Scholar]
- 3h. Reddy K. N., Rao M. V. K., Sridhar B., Reddy B. V. S., Chem. Asian J. 2019, 14, 2958–2965; [DOI] [PubMed] [Google Scholar]
- 3i. Yoshinaga Y., Yamamoto T., Suginome M., Angew. Chem. Int. Ed. 2020, 59, 7251–7255; [DOI] [PubMed] [Google Scholar]
- 3j. Rong M. Y., Li J.-S., Zhou Y., Zhang F.-G., Ma J.-A., Org. Lett. 2020, 22, 9010–9015. [DOI] [PubMed] [Google Scholar]
- 4.For recent examples by our groups:
- 4a. Romano F., Di Mola A., Tiffner M., Waser M., Massa A., Catalysts 2019, 9, 327; [Google Scholar]
- 4b. Monaco G., Tiffner M., Di Mola A., Herrebout W., Waser M., Massa A., Molecules 2020, 25, 2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.For intramolecular asymmetric 3-heterofunctionalizations:
- 5a. Jing K., Wang X.-N., Wang G.-W., J. Org. Chem. 2019, 84, 161–172; [DOI] [PubMed] [Google Scholar]
- 5b. Sengoku T., Miyoshim T Tsuda A., Inuzuka T., Sakamoto M., Takahashi M., Yoda H., Tetrahedron 2020, 76, 131252. [Google Scholar]
- 6.For asymmetric catalytic intermolecular approaches:
- 6a. Suc J., Dokli I., Gredicak M., Chem. Commun. 2016, 52, 2071–2074; [DOI] [PubMed] [Google Scholar]
- 6b. Suneja A., Unhale R. A., Singh V. K., Org. Lett. 2017, 19, 476–479; [DOI] [PubMed] [Google Scholar]
- 6c. Unhale R. A., Molleti N., Rana N. K., Dhanasekaran S., Bhandary S., Singh V. K., Tetrahedron Lett. 2017, 58, 145–151. [Google Scholar]
- 7. Steendam R. R. E., Kulka M. W., Meekes H., van Enckevort W. J. P., Raap J., Vlieg E., Rutjes F. P. J. T., Eur. J. Org. Chem. 2015, 7249–7252. [Google Scholar]
- 8.For two examples:
- 8a. Di Mola A., Scorzelli F., Monaco G., Palombi L., Massa A., RSC Adv. 2016, 6, 60780–60786; [Google Scholar]
- 8b. Scorzelli F., Di Mola A., De Piano F., Tedesco C., Palombi L., Filosa R., Waser M., Massa A., Tetrahedron 2017, 73, 819–828. [Google Scholar]
- 9.For complementary strategies to access compounds 1:
- 9a. Couture A., Deniau E., Ionescu P Grandclaudon D., Tetrahedron Lett. 1998, 39, 2319; [Google Scholar]
- 9b. Nieto S., Sayago F. J., Laborda P., Soler T., Cativiela C., Urriolabeitia E. P., Tetrahedron 2011, 67, 4185–4191; [Google Scholar]
- 9c. Dhanasekaran S., Suneja A., Bisai V., Singh V. K., Org. Lett. 2016, 18, 634–637; [DOI] [PubMed] [Google Scholar]
- 9d. Kayet A., Ajarul S., Paul S., Maiti D. K., J. Org. Chem. 2018, 83, 8401–8409. [DOI] [PubMed] [Google Scholar]
- 10.For selected reviews on asymmetric ammonium salt catalysis:
- 10a. Shirakawa S., Maruoka K., Angew. Chem. Int. Ed. 2013, 52, 4312–4348; [DOI] [PubMed] [Google Scholar]
- 10b. Tan J., Yasuda N., Org. Process Res. Dev. 2015, 19, 1731–1746; [Google Scholar]
- 10c. Kaneko S., Kumatabara Y., Shirakawa S., Org. Biomol. Chem. 2016, 14, 5367–5376; [DOI] [PubMed] [Google Scholar]
- 10d. Qia D., Sun J., Chem. Eur. J. 2019, 25, 3740–3751.30358913 [Google Scholar]
- 11.Reviews on bifunctional ammonium salt catalysis:
- 11a. Novacek J., Waser M., Eur. J. Org. Chem. 2013, 637–648; [Google Scholar]
- 11b. Wang H., Catalysts 2019, 9, 244; [Google Scholar]
- 11c. Wang H., Zheng C., Zhao G., Chin. J. Chem. 2019, 37, 1111–1119. [Google Scholar]
- 12.For two recent examples
- 12a. Eitzinger A., Briere J.-F., Cahard D., Waser M., Org. Biomol. Chem. 2020, 18, 405–408; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12b. Mairhofer C., Novacek J., Waser M., Org. Lett. 2020, 22, 6138–6142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Schörgenhumer J., Tiffner M., Waser M., Beilstein J. Org. Chem. 2017, 13, 1753–1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Reviews on trifluoromethylthiolations:
- 14a. Chachignon H., Cahard D., Chin. J. Chem. 2016, 34, 445–454; [Google Scholar]
- 14b. Hardy M. A., Chachignon H., Cahard D., Asian J. Org. Chem. 2019, 8, 591–609. [Google Scholar]
- 15.Recent ammonium salt-catalyzed examples:
- 15a. Wang X., Yang T., Cheng X., Shen Q., Angew. Chem. Int. Ed. 2013, 52, 12860–12864; [DOI] [PubMed] [Google Scholar]
- 15b. Capaccio V., Sicignano M., Rodriguez R. I., Della Sala G., Alemán J., Org. Lett. 2020, 22, 219–223. [DOI] [PubMed] [Google Scholar]
- 16.Reviews on sulfanylations:
- 16a. Wladislaw B., Marzorati L., di Vitta C., Org. Prep. Proced. Int. 2007, 39, 447–494; [Google Scholar]
- 16b. Chauhan P., Mahajan S., Enders D., Chem. Rev. 2014, 114, 8807–8864; [DOI] [PubMed] [Google Scholar]
- 16c. Xu X.-M., Chen D.-M., Wang Z.-L., Chin. Chem. Lett. 2020, 31, 49–57. [Google Scholar]
- 17.Recent phosphonium and ammonium salt-catalyzed examples:
- 17a. Shirakawa S., Tokuda T., Kasai A., Maruoka K., Org. Lett. 2013, 15, 3350–3353; [DOI] [PubMed] [Google Scholar]
- 17b. Cadart T., Berthonneau C., Levacher V., Perrio S., Briere J.-F., Chem. Eur. J. 2016, 22, 15261–15264. [DOI] [PubMed] [Google Scholar]
- 18.For selected reviews on asymmetric fluorination reactions:
- 18a. Ma J.-A., Cahard D., Chem. Rev. 2008, 108, PR1–PR43; [DOI] [PubMed] [Google Scholar]
- 18b. Liang T., Neumann C. N., Ritter T., Angew. Chem. Int. Ed. 2013, 52, 8214–8264; [DOI] [PubMed] [Google Scholar]
- 18c. Yang X., Wu T., Phipps R. J., Toste F. D., Chem. Rev. 2015, 115, 826–870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.
- 19a. Ooi T., Kameda M., Maruoka K., J. Am. Chem. Soc. 1999, 121, 6519–6520; [Google Scholar]
- 19b. Ooi T., Kameda M., Maruoka K., J. Am. Chem. Soc. 2003, 125, 5139–5151. [DOI] [PubMed] [Google Scholar]
- 20. Tiffner M., Novacek J., Busillo A., Gratzer K., Massa A., Waser M., RSC Adv., 2015, 5, 78941–78949. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.
- 21a. Berkessel A., Roland K., Schröder M., Neudörfl J. M., Lex J., J. Org. Chem. 2006, 71, 9312–9318; [DOI] [PubMed] [Google Scholar]
- 21b. Berkessel A., Roland K., Neudoerfl J.-M., Org. Lett. 2006, 8, 4195–4198. [DOI] [PubMed] [Google Scholar]
- 22.Experimental details can be found in the supporting information.
- 23.For reviews about chiral guanidine and guanidinium catalysts:
- 23a. Hosoya K., Odagi M., Nagasawa K., Tetrahedron Lett. 2018, 59, 687–696; [Google Scholar]
- 23b. Dong S., Feng X., Liu X., Chem. Soc. Rev. 2018, 47, 8525–8540; [DOI] [PubMed] [Google Scholar]
- 23c. Chou H.-C., Leow D., Tan C.-H., Chem. Asian J. 2019, 14, 3803–3822; [DOI] [PubMed] [Google Scholar]
- 23d. Wang Y.-H., Cao Z.-Y., Li Q.-H., Lin G.-Q., Zhou J., Tian P., Angew. Chem. Int. Ed. 2020, 59, 8004–8014. [DOI] [PubMed] [Google Scholar]
- 24.For impressive examples about the combination of guanidinium salts with (thio)-ureas:
- 24a. Sohtome Y., Hashimoto Y., Nagasawa K., Adv. Synth. Catal. 2005, 347, 1643–1648; [Google Scholar]
- 24b. Odagi M., Hosoya K., Yamamoto Y., Nagasawa K., Synlett 2017, 28, 1305–1309; [Google Scholar]
- 24c. Zhu B., Lee R., Yin Y., Li F., Coote M. L., Jiang Z., Org. Lett. 2018, 20, 429–432; [DOI] [PubMed] [Google Scholar]
- 24d. Zhu B., Fuyuan L., Bohua L., Chang J., Jiang Z., J. Org. Chem. 2018, 83, 11350–11358. [DOI] [PubMed] [Google Scholar]
- 25. He R., Shirakawa S., Maruoka K., J. Am. Chem. Soc. 2009, 131, 16620–16621. [DOI] [PubMed] [Google Scholar]
- 26.CCDC 2043501 (2 e) and CCDC 2042252 (4 a) contain the supplementary crystallographic data for this paper. These data are provided free of charge by the Cambridge Crystallographic Data Centre.
- 27.For a recent report on the synthesis of racemic 3-F-containing isoindolinones starting from isoindolinone enamides: Munoz S. B., Krishnamurti V., Barrio P., Mathew T., Prakash G. K. S., Org. Lett. 2018, 20, 1042–1045. [DOI] [PubMed] [Google Scholar]
- 28.For reports outlining these challenges:
- 28a. Takeuchi Y., J. Fluorine Chem. 2000, 105, 215–217; [Google Scholar]
- 28b. Huber D. P., Stanek K., Togni A., Tetrahedron: Asymmetry 2006, 17, 658–664. [Google Scholar]
- 29.For rare enantioselective approaches:
- 29a. Mohar B., Baudoux J., Plaquevent J.-C., Cahard D., Angew. Chem. 2001, 113, 4339–4341; [DOI] [PubMed] [Google Scholar]
- 29b. Mohar B., Sterk D., Ferron L., Cahard D., Tetrahedron Lett. 2005, 46, 5029–5031. [Google Scholar]
- 30.For two recent racemic approaches:
- 30a. Wei Q., Ma Y., Liu Q., Liu Z., Liu G., Org. Lett. 2018, 20, 7100–7103; [DOI] [PubMed] [Google Scholar]
- 30b. Sim J., Campbell M. W., Molander G. A., ACS Catal. 2019, 9, 1558–1563. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Seo M.-S., Kim H., J. Am. Chem. Soc. 2015, 137, 14190–14195. [DOI] [PubMed] [Google Scholar]
- 32.
- 32a. Winter M., Kim H., Waser M., Eur. J. Org. Chem. 2019, 7122–7127; [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32b. Jang S., Kim H., Org. Lett. 2020, 22, 7804–7808. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
Supplementary
